Our Pipeline

See where we’re heading

CureVac aims to leverage its unique technology to provide life-saving solutions for patients with the greatest need. That’s why we are moving forward with a strategic, purposeful mRNA-based pipeline focusing on three therapeutic areas in which we can truly make a difference: cancer immunotherapies, prophylactic vaccines and protein delivery.

mRNA-based Cancer Immunotherapies

Collaborations
Pre-Clinical Discovery
Pre-Clinical Development
Phase 1
Phase 2
Oncology

Shared neoantigens

Collaborations:
Close
Close

Tumor Associated Antigens (TAA)

Collaborations:
Close
Close

Solid tumor program
(mRNA intratumoral cocktail)

Collaborations:
Close
Close

Protein-based therapies

Collaborations
Pre-Clinical Discovery
Pre-Clinical Development
Phase 1
Phase 2
Protein Delivery

Liver metabolic disorders
(rare diseases, fibrosis)

Collaborations:
Close
Close

Ocular diseases

Collaborations:
Close
Close

Lung respiratory diseases

Collaborations:
Close
Close

Therapeutic antibodies

Collaborations:
Close
Close

mRNA-based Prophylactic Vaccines

Collaborations
Pre-Clinical Discovery
Pre-Clinical Development
Phase 1
Phase 2
Prophylactic Vaccines

COVID-19

Collaborations:
Close
Close

Lassa, Yellow Fever

Collaborations:
Close
Close

Respirational Syncytial Virus

Collaborations:
Close
Close